Global, regional, and national burden of Alzheimer’s disease and other dementias with a focus on populations aged 40 years and older, 1990–2023, and projections to 2040: a systematic analysis based on the Global Burden of Disease Study 2023
Neuroepidemiology · 17.11.2026
DOI: 10.1159/ned/adwag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, online erschienen am 17.11.2026. Verfasst von Rui Yu und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Objective
To comprehensively assess long-term epidemiological trends in Alzheimer’s disease and other dementias (ADOD) from 1990 to 2023 using data from the Global Burden of Disease Study 2023 (GBD 2023), and to project future burden to 2040 globally and in China.
Methods
We analysed age-standardised prevalence, incidence, mortality, and disability-adjusted life years (DALYs) across 204 countries and territories. Temporal trends were assessed using Joinpoint regression. Decomposition analysis quantified the contributions of population growth, population ageing, and epidemiological change to burden increases. Socioeconomic inequality was evaluated using concentration indices. Bayesian age–period–cohort models were applied to project age-specific burden through 2040.
Results
From 1990 to 2023, global age-standardised rates of ADOD remained broadly stable, whereas absolute numbers increased substantially, driven primarily by population ageing and population growth. Women consistently experienced higher burden than men across all metrics. Burden levels were highest in high sociodemographic index (SDI) settings, while the fastest growth occurred in middle and low SDI regions. Risk attribution analyses identified high fasting plasma glucose as the leading modifiable contributor to ADOD burden globally. Projections indicated that future increases will be highly concentrated among adults aged 70 years and older. In China, age-standardised prevalence and incidence among adults aged ≥40 years are projected to rise more steeply than the global average, particularly in older age groups.
Conclusion
Although age-standardised rates of ADOD are stabilising globally, population ageing will continue to drive a rapidly growing absolute burden over the next two decades. The concentration of future burden in older adults and in rapidly ageing middle-income countries underscores the need for age-targeted prevention strategies, early metabolic risk control, and health-system planning that explicitly accounts for age structure and socioeconomic inequality.
Zitieren
APA
Yu, R., Wang, T., Sun, S., Xu, Y., Xia, H., He, H., Han, L., Wang, Y., Zhang, T., & Chen, X. (2026). Global, regional, and national burden of Alzheimer’s disease and other dementias with a focus on populations aged 40 years and older, 1990–2023, and projections to 2040: a systematic analysis based on the Global Burden of Disease Study 2023. Neuroepidemiology. https://doi.org/10.1159/ned/adwag034
Vancouver
Yu R, Wang T, Sun S, Xu Y, Xia H, He H, et al. Global, regional, and national burden of Alzheimer’s disease and other dementias with a focus on populations aged 40 years and older, 1990–2023, and projections to 2040: a systematic analysis based on the Global Burden of Disease Study 2023. Neuroepidemiology. 2026. doi:10.1159/ned/adwag034
BibTeX
@article{Yu2026,
author = {Yu, Rui and Wang, Tingting and Sun, Shujun and Xu, Younian and Xia, Haifa and He, Hao and Han, Linlin and Wang, Yafeng and Zhang, Tao and Chen, Xiangdong},
title = {Global, regional, and national burden of Alzheimer’s disease and other dementias with a focus on populations aged 40 years and older, 1990–2023, and projections to 2040: a systematic analysis based on the Global Burden of Disease Study 2023},
journal = {Neuroepidemiology},
year = {2026},
doi = {10.1159/ned/adwag034}
}
EUVIMED